• Home
  • Products
    • PreciseInhale®
      • Precision dosing
      • With inhalers
      • With nebulizers
      • Purchase or CRO?
      • White paper
    • Inhalation Research Services (IRS)
      • Aerosol characterization
      • DissolvIt®: in vitro dissolution
      • IPL ex vivo
      • Intratracheal in vivo
      • Nose-only in vivo
    • DissolvIt ®: in vitro
    • XposeALI ®
    • Nose-only
    • Intratracheal
    • IPL: ex vivo
    • Technical specifications
  • Publications
  • About
    • About Us
    • Our Customers
    • Management
    • Our Team
    • Board
  • News
  • Investors / investerare
    • Bolagsanalys
    • Pressmeddelanden
    • Prenumerera
    • IPO 2017
    • Finansiella rapporter
    • Kalender
    • Ägarlista
    • Bolagstämma
    • Bolagsstyrning
    • Presentationer
  • Contact
    • Meet Us
    • Privacy policy
  • Swedish
  • English
Inhalation
  • Home
  • Products
    • PreciseInhale®
      • Precision dosing
      • With inhalers
      • With nebulizers
      • Purchase or CRO?
      • White paper
    • Inhalation Research Services (IRS)
      • Aerosol characterization
      • DissolvIt®: in vitro dissolution
      • IPL ex vivo
      • Intratracheal in vivo
      • Nose-only in vivo
    • DissolvIt ®: in vitro
    • XposeALI ®
    • Nose-only
    • Intratracheal
    • IPL: ex vivo
    • Technical specifications
  • Publications
  • About
    • About Us
    • Our Customers
    • Management
    • Our Team
    • Board
  • News
  • Investors / investerare
    • Bolagsanalys
    • Pressmeddelanden
    • Prenumerera
    • IPO 2017
    • Finansiella rapporter
    • Kalender
    • Ägarlista
    • Bolagstämma
    • Bolagsstyrning
    • Presentationer
  • Contact
    • Meet Us
    • Privacy policy
  • Bolagsanalys
  • Pressmeddelanden
  • Prenumerera
  • IPO 2017
  • Finansiella rapporter
  • Kalender
  • Ägarlista
  • Bolagstämma
  • Bolagsstyrning
  • Presentationer

Bolagstämma

Inhalation Sciences Swedens valberedning inför årsstämman 2021

ISAB – Meddelande valberedning 2021

Extra bolagsstämma den 12 juni 2020

ISAB – kallelse till EBS

ISAB EBS20 – Forslag till incitamentsprogram till styrelseledamoter 

ISAB EBS20 – Forslag till incitamentsprogram till VD (FINAL)

ISAB EBS20 – Fullmaktsformular (2)

ISAB – Optionsvillkor TO 20202022 (Bilaga A)

ISAB – Revisorsyttrande 14-8

Styrelsens redogorelse , Signed

ISAB Kommunike ES juni 12

Här finner du information om bolagets Årsstämma 2020:

Årsstämma 12 maj 2020

ISAB AS20 – Fullmaktsformular

ISAB EBS20 Rostrattsfullmakt

 

 

Contact

Hälsovägen 7
Novum Floor 6, Elevator E
141 57 Huddinge, Sweden.
contact@inhalation.se
+46 (0) 705 625 195

Visitor entrance: Blickagången 6, Floor 6, Elevator E

Meny
  • Home
  • Products
    • PreciseInhale®
      • Precision dosing
      • With inhalers
      • With nebulizers
      • Purchase or CRO?
      • White paper
    • Inhalation Research Services (IRS)
      • Aerosol characterization
      • DissolvIt®: in vitro dissolution
      • IPL ex vivo
      • Intratracheal in vivo
      • Nose-only in vivo
    • DissolvIt ®: in vitro
    • XposeALI ®
    • Nose-only
    • Intratracheal
    • IPL: ex vivo
    • Technical specifications
  • Publications
  • About
    • About Us
    • Our Customers
    • Management
    • Our Team
    • Board
  • News
  • Investors / investerare
    • Bolagsanalys
    • Pressmeddelanden
    • Prenumerera
    • IPO 2017
    • Finansiella rapporter
    • Kalender
    • Ägarlista
    • Bolagstämma
    • Bolagsstyrning
    • Presentationer
  • Contact
    • Meet Us
    • Privacy policy
About Us

Inhalation Sciences develops and sells patented, highly innovative labtech equipment for inhalation research. Scientists using it can now know, with unprecedented accuracy, how particles behave in our lungs when we inhale them: whether new pollutants or life-saving drugs that power human development.

Copyright © 2021 Inhalation. All rights reserved.

Design mkmedia
To top

We use cookies to give you a better experience of Inhalation. Read more about Cookies

I Approve